サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：in vitro（体外）毒性試験の世界市場：2023-2030年
市場調査レポート
商品コード
1380468

in vitro（体外）毒性試験の世界市場：2023-2030年

Global In-Vitro Toxicology Testing Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
in vitro（体外）毒性試験の世界市場：2023-2030年
出版日: 2023年10月02日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のin vitro（体外）毒性試験市場は、予測期間中に10.5%というかなりのCAGRで成長すると予測されています。製薬研究費の大幅な増加は、in vitro（体外）毒性試験の成長を促進する主な要因です。製薬会社による研究開発費の増加や、前臨床開発段階に入る新薬の増加により、in vitro（体外）毒性試験の需要も増加しています。前臨床パイプラインの生産能力の大幅な増加と、in vitro試験サービスの利点に関する意識の高まりが、世界市場の成長を促進しています。加えて、動物実験にかかる従来のコストの上昇や社会倫理的な問題が、さらに市場成長に寄与しています。医薬品の安全性を評価し、それらの医薬品が細胞や組織に与える潜在的な影響を評価するために使用されるin vitro（体外）試験アッセイの大幅な市場開拓は、市場成長に貢献する他のいくつかの要因です。

増大する需要に対応するため、主要企業は新たな施設を開設したり投資したりしています。例えば、2023年4月、医薬品と栄養補助食品の賦形剤を提供するRoquette社は、フィラデルフィア近郊に新しい医薬品イノベーションセンターを開設しました。2,500万米ドルを投じたこの新センターは、世界中の製薬・栄養補助食品メーカーのための高度なトレーニングとコラボレーションの拠点となります。次世代の経口剤形による患者体験の最適化に焦点を当てた米国の施設は、フランスとシンガポールにあるロケットの既存の医薬品イノベーションセンターの最先端研究活動を補完するものです。こうした研修やセンターの主要な研究プロジェクトを支えるのは、最新の医薬品加工・試験・製造設備一式です。

同月、ミリポア・シグマ社は、スコットランドのバイオセーフティ試験強化のために3,750万米ドルを投資しました。この投資には、グラスゴーに1200m2の新施設を建設し、分子生物学とシークエンシングサービスを行うことが含まれており、同社は現在の建物にバイオセーフティ試験、分析開発、ウイルスクリアランススイートを追加し、試験能力を拡大する予定です。

セグメント別の展望

細胞培養が世界のin vitro（体外）毒性試験市場で圧倒的なシェアを占める

細胞培養技術セグメントは2022年にかなりのシェアを占めました。細胞培養は、一貫性のあるサンプルに対して再現性のある結果を提供し、毒性アッセイの優れたモデルとして機能します。そのため、毒性試験の実施に大いに採用されています。この技術はさらに、早期の薬物毒性試験を可能にし、そのためこの技術は世界中で人気と広範な応用を獲得しています。

地域展望

世界のin vitro（体外）毒性試験市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋地域（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。アジア太平洋地域は、世界のin vitro（体外）毒性試験市場で最も高いCAGRを示すと予想されています。新興経済国の企業が地域ヘルスケアを強化するために投資を増やしていることが、この地域の市場成長の主な促進要因となっています。新しいヘルスケア施設の設立と主要検査施設との提携は、市場成長にさらに貢献しています。

北米はin vitro（体外）毒性試験の世界市場でかなりのシェアを占める

北米は2022年のin vitro（体外）毒性試験市場でかなりのシェアを占めました。この地域市場は、主要なin vitro（体外）毒性試験サービスプロバイダーの存在によって牽引されています。慢性疾患に対する新規治療薬開発のための研究開発投資の増加が、市場成長にさらに寄与しています。EFPIA加盟団体によると、米国は2020年に医薬品研究開発に724億1,200万米ドルを投資しています。また、同地域は可処分所得が比較的高いため、高価な医薬品や医療処置を購入する余裕があります。このため、同地域では医薬品に対する旺盛な需要が生まれており、同地域市場の成長にさらに寄与しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Abbott Laboratories
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Bio-Rad Laboratories
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Agilent Technologies Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • in vitro（体外）毒性試験の世界市場：技術別
    • 細胞培養
    • ハイスループット
    • 分子イメージング
    • オミックス
  • in vitro（体外）毒性試験の世界市場：手法別
    • 細胞アッセイ
    • 生化学アッセイ
    • in silica
    • ex vivo
  • in vitro（体外）毒性試験の世界市場：用途別
    • 系統的毒性試験
    • 経皮毒性
    • 内分泌攪乱物質
    • 眼毒性
    • その他
  • in vitro（体外）毒性試験の世界市場：エンドユーザー別
    • 製薬・バイオテクノロジー
    • 診断
    • その他

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Agilent Technolgies, Inc.
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corp.
  • Eurofins Scientific
  • Evotec S.E.
  • Gentronix
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Quest Diagnostics Inc.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL CELL CULTURE BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL HIGH THROUGHPUT BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MOLECULAR IMAGING BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OMICS BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 7. GLOBAL CELLULAR ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL BIOCHEMICAL ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL IN SILICA BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 10. GLOBAL EX VIVO BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 12. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR SYSTEMATIC TOXICOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 13. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DERMAL TOXICITY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 14. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR ENDOCRINE DISRUPTION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 15. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OCCULAR TOXICITY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 16. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 18. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR PHARMACEUTICAL AND BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 19. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 20. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER END-USER MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 29. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 30. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 34. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 35. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 36. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 40. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL CELL CULTURE BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL HIGH THROUGHPUT BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR IMAGING BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OMICS BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL EX VIVO IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY METHOD, 2022 VS 2030 ($ MILLION)
  • 8. GLOBAL CELLULAR ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BIOCHEMICAL ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL IN SILICA BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL EX VIVO BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR SYSTEMATIC TOXICOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DERMAL TOXICITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR ENDOCRINE DISRUPTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OCCULAR TOXICITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR PHARMACEUTICAL AND BIOTECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR VETERINARY HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 21. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR EX VIVO END-USER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 23. US IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. UK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 35. REST OF ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027767

Title: Global In-vitro toxicology testing Market Size, Share & Trends Analysis Report, by Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS), by Method (Cellular Assay, Biochemical Assay, In Silica, Ex Vivo), by Application (Systematic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Other Applications), by End-User (Pharmaceutical and Biotechnology, Diagnostics, Other End-Users)Forecast Period (2023-2030).

The global in-vitro toxicology testing market is anticipated to grow at a considerable CAGR of 10.5% during the forecast period. A considerable rise in pharmaceutical research expenditure is a key factor driving the growth of the in-vitro toxicology testing. Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for in-vitro toxicology testing. A significant increase in preclinical pipeline capacity along with growing awareness about the benefits of in-vitro testing services is driving the global market growth. In addition, the traditional rising cost of animal tests as well as their socio-ethical problems is further contributing to the market growth. Significant developments in the in-vitro testing assays used to evaluate the security of medicines and the potential impacts of those drugs on cells and tissues are some other contributors to the market growth.

To meet the growing demand key players are opening or investing new facilities. For instance, in April 2023, Roquette, a provider of pharmaceutical and nutraceutical excipients, opened its new pharmaceutical innovation center near Philadelphia. The new $25 million center will be an advanced training and collaboration hub for pharmaceutical and nutraceutical manufacturers across the globe. With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette's existing pharma innovation centers in France and Singapore. Underpinning these training sessions and the center's primary research projects is a suite of the latest pharmaceutical processing, testing, and manufacturing equipment.

In the same month, Millipore Sigma has invested $37.5 million to strengthen biosafety testing in Scotland. The investment includes a new 1200-m2 facility in Glasgow that will house molecular biology and sequencing services, and the company will add biosafety testing, analytical development, and viral clearance suites in its current buildings to expand testing capacity.

Segmental Outlook

The global in-vitro toxicology testing market is segmented based on technology, method, application, and end-user. Based on technology, the market is segmented into in cell culture, high throughput, molecular imaging, and OMICS. Based on method, the market is sub-segmented into cellular assay, biochemical assay, in silica, and ex vivo. Based on application, the market is sub-segmented into systematic toxicology, dermal toxicity, endocrine disruption, ocular toxicity, and other applications. Based on end-user, the market is sub-segmented into pharmaceutical and biotechnology, diagnostics, and other end-users.

Cell Culture Holds a Prominent Market Share in the Global In-vitro toxicology testing Market

The cell culture technology segment held considerable share in 2022. The cell cultures provide reproducible results to consistent samples, and serve as excellent models for toxicology assays. Hence, it is highly adopted to perform toxicology testing. This technology further enables early stage drug toxicity testing due to which this technology is gaining popularity & extensive application across the globe.

Regional Outlook

The global in-vitro toxicology testing market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit highest CAGR in the global in-vitro toxicology testing market. The rising investment by companies from emerging economies in enhancing regional healthcare is a key promoter to the regional market growth. Establishment of new healthcare facilities along with alliances formation with major laboratories is further contributing to the market growth.

North America held Considerable Share in the Global In-Vitro Toxicology Testing Market

North America held considerable share in in-vitro toxicology testing market in 2022. The regional market is driven by the presence of key in-vitro toxicology testing service providers. The rising investments in R&D for the development of novel therapeutics for chronic diseases are further contributing to the market growth. According to EFPIA member associations in 2020, the US has invested $72,412 million in pharmaceutical R&D. Besides, the region has a relatively high disposable income, which enables people to afford expensive drugs and medical treatments. This creates a strong demand for pharmaceutical products in the region; which is further contributing to the regional market growth.

Market Players Outlook

The major companies serving the global in-vitro toxicology testing market include: Abbott Laboratories, Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., and Eurofins Scientific SE among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global in-vitro toxicology testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio-Rad Laboratories
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Agilent Technologies Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global In-vitro Toxicology Testing Market by Technology
    • 4.1.1. Cell Culture
    • 4.1.2. High Throughput
    • 4.1.3. Molecular Imaging
    • 4.1.4. OMICS
  • 4.2. Global In-vitro Toxicology Testing Markey by Method
    • 4.2.1. Cellular Assay
    • 4.2.2. Biochemical Assay
    • 4.2.3. In Silica
    • 4.2.4. Ex Vivo
  • 4.3. Global In-vitro Toxicology Testing Market by Application
    • 4.3.1. Systematic Toxicology
    • 4.3.2. Dermal Toxicity
    • 4.3.3. Endorine Disruption
    • 4.3.4. Occular Toxicity
    • 4.3.5. Other Applications
  • 4.4. Global In-vitro Toxicology Testing Market by End-User
    • 4.4.1. Pharmaceutical and Biotechnology
    • 4.4.2. Diagnostics
    • 4.4.3. Other End-Users

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Agilent Technolgies, Inc.
  • 6.3. BioIVT
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. Catalent, Inc.
  • 6.6. Charles River Laboratories International, Inc.
  • 6.7. Danaher Corp.
  • 6.8. Eurofins Scientific
  • 6.9. Evotec S.E.
  • 6.10. Gentronix
  • 6.11. Laboratory Corporation of America Holdings
  • 6.12. Merck KGaA
  • 6.13. Quest Diagnostics Inc.
  • 6.14. SGS S.A.
  • 6.15. Thermo Fisher Scientific, Inc.